Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 1317-26-6
2. Aluminum Hydroxide/magnesium Hydroxide
3. Aluminum Hydroxide/magnesium Hydroxide - Magaldrate C410
4. Aluminum Hydroxide/magnesium Hydroxide - Magaldrate C632
Molecular Weight | 86.310 g/mol |
---|---|
Molecular Formula | AlH3MgO2- |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 0 |
Exact Mass | 85.9798844 g/mol |
Monoisotopic Mass | 85.9798844 g/mol |
Topological Polar Surface Area | 2 Ų |
Heavy Atom Count | 4 |
Formal Charge | -1 |
Complexity | 0 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 4 |
A02AD02
S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Dosage Form : Tablet
Grade : Oral
Application : Solubilizers
Excipient Details : HPC-SSL SFP is used as a binder and solubilizer in solid dosage forms including tablets, capsules, granules, and pellets.
Pharmacopoeia Ref : EP, JP, USP/NF, CEP, GMP, Hala...
Technical Specs : N/A
Ingredient(s) : Hydroxypropyl Cellulose
Dosage Form : Tablet
Grade : Oral
Dosage Form : Tablet
Grade : Oral
Dosage Form : Tablet
Grade : Oral
Dosage Form : Tablet
Grade : Oral
Dosage Form : Tablet
Grade : Oral
Dosage Form : Tablet
Grade : Oral
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Magaldrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Magaldrate, including repackagers and relabelers. The FDA regulates Magaldrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Magaldrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Magaldrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Magaldrate supplier is an individual or a company that provides Magaldrate active pharmaceutical ingredient (API) or Magaldrate finished formulations upon request. The Magaldrate suppliers may include Magaldrate API manufacturers, exporters, distributors and traders.
click here to find a list of Magaldrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Magaldrate DMF (Drug Master File) is a document detailing the whole manufacturing process of Magaldrate active pharmaceutical ingredient (API) in detail. Different forms of Magaldrate DMFs exist exist since differing nations have different regulations, such as Magaldrate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Magaldrate DMF submitted to regulatory agencies in the US is known as a USDMF. Magaldrate USDMF includes data on Magaldrate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Magaldrate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Magaldrate suppliers with USDMF on PharmaCompass.
A Magaldrate written confirmation (Magaldrate WC) is an official document issued by a regulatory agency to a Magaldrate manufacturer, verifying that the manufacturing facility of a Magaldrate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Magaldrate APIs or Magaldrate finished pharmaceutical products to another nation, regulatory agencies frequently require a Magaldrate WC (written confirmation) as part of the regulatory process.
click here to find a list of Magaldrate suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Magaldrate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Magaldrate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Magaldrate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Magaldrate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Magaldrate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Magaldrate suppliers with NDC on PharmaCompass.
Magaldrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Magaldrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Magaldrate GMP manufacturer or Magaldrate GMP API supplier for your needs.
A Magaldrate CoA (Certificate of Analysis) is a formal document that attests to Magaldrate's compliance with Magaldrate specifications and serves as a tool for batch-level quality control.
Magaldrate CoA mostly includes findings from lab analyses of a specific batch. For each Magaldrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Magaldrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Magaldrate EP), Magaldrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Magaldrate USP).
LOOKING FOR A SUPPLIER?